The protein A-gold immunocytochemical technique was applied to reveal the monomeric elements M1, M2* and M3 from the non-collagenous globular domain (NC1) of type IV collagen over various renal basement membranes from control and long-term streptozotocin-induced diabetic rats. This study includes the basement membranes of the proximal tubule, the Bowman's capsule and the glomerulus as well as the extracellular matrix of the mesangium. The labellings obtained were confined to basement membrane material. The quantitative analysis demonstrated changes in labelling intensities and distribution between tissues from normal and diabetic animals. Increased labelling intensities were observed for M1 and M2* monomers in all the basement membranes studied except for the mesangial matrix which remained unchanged. In addition, the labelling for M1 monomers, present on the endothelial side of the glomerular basement membrane of control animals, was found to be distributed throughout the entire thickness of the basement membrane of diabetic animals. In contrast, neither the intensity of the labelling, nor the distribution of M3 monomers were altered in diabetic animals. Since M1 monomers are markers of the cd(IV) and c~2(IV) chains of type IV collagen while M2* and M3 mark cG(IV) and cd(IV) chains respectively, the present results demonstrate changes in the nature of the collagenous elements of basement membranes during diabetes. Furthermore, the results indicate that the cG(IV) and the c~4(IV) chains are not necessarily present in the same molecule. The modifications of the collagenous elements of the basement membranes during diabetes must alter the structural characteristics of these matrices which in turn might influence their functional properties.
Summary.
The protein A-gold immunocytochemical technique was applied to reveal the monomeric elements M1, M2* and M3 from the non-collagenous globular domain (NC1) of type IV collagen over various renal basement membranes from control and long-term streptozotocin-induced diabetic rats. This study includes the basement membranes of the proximal tubule, the Bowman's capsule and the glomerulus as well as the extracellular matrix of the mesangium. The labellings obtained were confined to basement membrane material. The quantitative analysis demonstrated changes in labelling intensities and distribution between tissues from normal and diabetic animals. Increased labelling intensities were observed for M1 and M2* monomers in all the basement membranes studied except for the mesangial matrix which remained unchanged. In addition, the labelling for M1 monomers, present on the endothelial side of the glomerular basement membrane of control animals, was found to be distributed throughout the entire thickness of the basement membrane of diabetic animals. In contrast, neither the intensity of the labelling, nor the distribution of M3 monomers were altered in diabetic animals. Since M1 monomers are markers of the cd(IV) and c~2(IV) chains of type IV collagen while M2* and M3 mark cG(IV) and cd(IV) chains respectively, the present results demonstrate changes in the nature of the collagenous elements of basement membranes during diabetes. Furthermore, the results indicate that the cG(IV) and the c~4(IV) chains are not necessarily present in the same molecule. The modifications of the collagenous elements of the basement membranes during diabetes must alter the structural characteristics of these matrices which in turn might influence their functional properties.
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Capillary basement membranes are the sites of major morphological and biochemical alterations during diabetes. In the kidney, spreading of the mesangial matrix and thickening of the glomerular basement membrane are the most striking morphological alterations [1] [2] [3] [4] which occur concomitant to a progressive impairment of the functional properties with loss of the glomerular permselectivity and increase proteinuria [5] [6] [7] [8] . Alterations in the composition of the glomerular basement membrane in diabetic patients as well as in experimentally induced diabetic rats have also been reported. Although challenged, they mainly consist in alterations of the amino acids and glycoconjugates composition [9] [10] [11] [12] [13] [14] [15] , as well as in modifications of the content of their macromolecular components [16] [17] [18] [19] , such as type IV collagen, laminin, and proteoglycans. In addition to the biochemical increase of type IV collagen, its distribution within the glomerular basement membrane was found to be modified [20] . These modifications are believed to influence the molecular organization of the glomerular basement membrane which in turn must alter its physiological properties.
Type IV collagen molecules have been shown to interact among themselves to form the basic framework of basement membranes [21] [22] [23] [24] [25] [26] [27] . Recent data demonstrated that the non-collagenous domain (NC1) from two a&--jacent type IV collagen molecules, extracted from bovine glomerular basement membrane, is made of four types of monomeric structures namely Mla, Mlb, M2* and M3 [28, 29] . Biochemical analysis showed that Mla and Mlb monomers are associated to the c~I(IV) and (x2(IV) chains of type IV collagen, while M2* and M3 are considered as part of two new chains designated c~3(IV) and a4(IV) respectively [29] . These monomers are not evenly distributed within the normal renal basement membranes as demonstrated by immunofluorescence [30, 31] and the high resolution immunogold technique [32] confirming the concept of basement membrane heterogeneity [33] . In diabetic patients, we have previously shown by immunofluorescence that mesangial sclerosis is associated with accumulation of solely M1 monomers, whereas both M1 and M2* monomers participate in the thickening of the glomerular basement membrane [34] . The aim of the present study was to further investigate, at the ultrastructural level, changes in the distribution of M1, M2* and M3 monomers in renal basement membranes during diabetes. To do so, the protein A-gold technique was applied to localize the antigenic sites of these peptides in renal tissues from control and long-term streptozotocin-induced diabetic rats. The high resolution of the labelling achieved by the use of the gold marker has further enabled morphometrical analysis. The results revealed changes in the pattern of labelling of the monomers indicating alterations of type IV collagen chains in basement membranes during diabetes.
Materials and methods
An experimental chronic hyperglycaemic state was induced in 100 g Sprague-Dawley male rats by an intraperitoneal injection of streptozotocin (70 mg/kg body weight, in citrate buffer 10 mmol/1, pH 4.5). Control animals only received an injection of the citrate buffer. The animals of the experimental group remained hyperglycaemic throughout the entire length of the experiment, as demonstrated by the frequent glycosuria and occasional glycaemia measurements made using the Multistix and Dextrostix reagent strips (Miles, Ames, Ontario, Canada), while those injected with the citrate buffer remained normoglycaemic. The animals were fed ad libitum with standard rat chow and had free access to water. After 12 months of hyperglycaemia the rats were killed by decapitation and blood samples were taken for the determination of glucose and insulin levels. These were performed respectively by the glucose oxidase method and radioimmunoassay. Small fragments of cortical rat kidney were immediately fixed by immersion in periodate-lysine, paraformaldehyde 4% solution [35] for 2 h at 4~ The tissue fragments were then rinsed in 0.1 mol/1 phosphate buffer, dehydrated in methanol and embedded in Lowicryl K4M at -20~ as described previously [3@ Thin sections were cut, mounted on nickel grids coated with Parlodion and carbon films and processed for the cytochemical labelling.
Specific polyclonal antibodies raised in rabbits immunized with M1, M2* and M3 monomers of the globular (NC1) domain of type IV collagen extracted from bovine glomerular basement membrane were used [37] . These antibodies have been shown to crossreact with human and rat antigens by immunochemical and cytochemical approaches [32, 34] . On the other hand, amino-acid sequences of the NC1 peptides from various species were found to be highly homologous [38, 39] . M1 and M2* antibodies (IgG fractions) and a complete M3 antiserum [28, 40] were combined with the protein A-gold technique [36] to reveal the corresponding antigenic sites on the renal tissues as described previously [32] .
In brief, tissue sections were incubated for 5 min on a drop of 0.01 tool/1 phosphate buffered saline, pH 7.3 (PBS) containing 1% ovalbumin, transferred to a drop of the antibody and incubated at room temperature for 90 rain. The grids were then rinsed with PBS, incubated with the PBS ovalbumin solution for 5 min and then with the protein A-gold for 30 min at room temperature. They were then washed with PBS, rinsed with distilled water and dried. Staining with uranyl acetate and lead citrate was performed prior to examination with a Siemens 101 electron microscope. For each antigen, the labelling procedure was performed simultaneously on tissue sections from all the animals. Protein A-gold complex was prepared with 15 nm gold particles as described previously [36] . The specificity of the antibodies was assessed through immunoblot experiments [28, 40] . In addition, experiments were performed in order to control the specificity of the labellings; these included incubation of the tissue sections with a normal serum prior to the protein A-gold complex, and incubation of the tissue sections with the protein A-gold complex alone [32] .
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A quantitative evaluation of the intensity of labelling was performed as described previously [33] for each antigen over the following renal basement membranes: the glomerular basement membrane, the extracellular matrix of the mesangial area, the epithelial basement membrane of the Bowman's capsule and that of the proximal convoluted tubule. The proximal tubule was identified according to its morpholoNcal characteristics. The quantitative evaluation was performed as follows: the tissues were first observed at low magnification at which the labelling is undiscernible. At least four glomeruli per animal were then selected randomly. For each antigen, and for each animal in both groups (four animals per group), 12 micro~aphs of each type of basement membrane were recorded and brought to a final magnification of 48,000X. The intensity of labelling, evaluated as the number of gold particles per unit of area of basement membrane, was determined using a MOP-3 electronic digitizer (Carl Zeiss Inc., Qurbec, Canada).
In a second study, the labellings obtained for the three antigens were further analysed to determine the ultrastructural distribution of each monomer over the thickness of the glomerular basement membrane. To do so, a Bioquant image analyzer program coupled to an Apple IIe computer was used. In a first step, the distance "d" between each gold particle and the abluminal membrane of the endothelial cell was measured. The thickness "T" of the glomerular basement membrane at the same site was then measured. The ratio (R = d/T) was calulated and the results, obtained for each antigen in each group of animals, were reported as histograms illustrating the distribution of the gold particles over the basement membrane thickness as described previously [41] . For this part of the study, an average of over one thousand gold particles was analysed for each antigen in each group.
Statistical analysis
Statistical analyses were performed between control and diabetic animals using the Student's t-test. Significance threshold was fixed a priori top < 0.05.
Results
The streptozotocin injection induced an hyperglycaemic state 24 h after its administration. High blood glucose levels were consistently detected in the diabetic animals throughout the entire length of the experiment which lasted 12 months. Indeed, the diabetic animals displayed higher blood glucose with glucosuria when compared to the controls. In addition, at the time of sampling, blood glucose and insulin levels for diabetic animals averaged 19.9 + 1.1 mmol/1 and 26.7 + 1.2 mU/1 respectively, vs 8.2 + 0.2 mmol/1 and 76.7 + 16.4 mU/1 for the controls. Previous studies have also shown that the hyperglycaemic state induced by streptozotocin was retained throughout the entire length of the experiment if no insulin treatment was given [42] . In addition to the hyperglycaemic state the animals developed characteristic cataract lesions and impairment of weight gain. Typical alterations of diabetic glomerulosclerosis were present in renal tissues from the hyperglycaemic animals. A thickening of the basement membranes and accumulation of mesangial matrix were observed [41, 42] . The morphometrical analysis confirmed these observations, the glomerular basement membrane thickness of the diabetic animals averaging 429.7 + 2.6 nm vs 334.2 + 2.6 nm for the age matched controls (p < 0.01). The antigenic sites of M1, M2* and M3 monomers of the NC1 domain of type IV collagen were revealed over various renal basement membranes of the control and diabetic rats. The results are illustrated in Figures 1-4 . In each case, the labellings were restricted to basement membrane material, only a few gold particles being present over other extracellular structures. In control animals, labelling of high intensities were observed for M1 monomers over the proximal tubule and the Bowman's capsule basement membranes (Fig. 1 a) as well as over the mesangial matrix (Fig.lb) . These labellings appeared distributed over the entire area of the basement membranes. On the other hand, the labelling of the glomerular basement membrane was of lower intensity and present mainly on the endothelial side of the basement m e m b r a n e (Figs. i a and 4 a) . In diabetic animals, the proximal tubule and the Bowman's capsule basement membranes (Fig. 1 c) , as well as the mesangial matrix (Fig. 1 d) , re- mained highly labelled. The first two being more intensely labelled than in control animals. The glomerular basement membrane (Fig.4b ) also appeared to be more intensely labelled than in controls. However, and in contrast to the normal condition, the labelling for M1 was observed over the entire thickness of the glomerular basement membrane (Fig. 4b) . The labellings for M2* m o n o m e r in the control animals were intense over the glomerular (Fig. 4c) and the proximal tubule basement membranes, The Bowman's capsule basement membrane was labelled with lower intensity, while the mesangial matrix (Fig. 2 a) displayed only few gold particles. In diabetic animals, while the mesangial matrix (Fig. 2b) remained weakly labelled, the labelling of the proximal tubule, the Bowman's capsule and the glomerular basement membranes (Fig. 2 c  and 4d ) appeared to be more intense than that of the controls. In all cases, the spatial distribution of M2* labellings remained similar. Labellings for M3 monomer in control animals were found over the proximal tubule, the Bow- No modification in the distribution of these monomers is observed in diabetic animals (over one thousand gold particles were analysed for each monomer in both groups of animals) man's capsule (Fig.3a) and the glomerular basement membranes (Fig.4e) , while the mesangial matrix was practically unlabelled. No major difference was observed in the diabetic animals; the proximal tubule and the Bowman's capsule basement membranes (Fig. 3b) , as well as the glomerular basement membranes (Fig.4f) were labelled, while the mesangial matrix (Fig. 3 c) remained very weakly labelled. A quantitative analysis of the intensity of labelling for each monomer in the various renal basement membranes was performed. The results, expressed as number of gold particles per gm 2 of basement membrane as well as their statistical analysis, are reported in Table 1 . They indicate that the different basement membranes studied are heterogeneous in terms of their respective labelling for each antigen. This was found to be the case in both control and diabetic animals. Furthermore, they reveal an important increase in intensities of the labelling for M1 and M2* monomers during diabetes. This increase was observed in all basement membranes except for the mesangial matrix, the labelling of which was unchanged during diabetes (Table 1) . Conversely, for M3 monomer, no difference in intensities of labelling was found between basement membranes of control and diabetic animals.
The labelling over the glomerular basement membrane was further analysed to determine the spatial distribution of M1, M2* and M3 monomers through the thickness of the basement membrane. The results presented as histograms are shown in Figure 5 . In control animals, labelling for M1 monomers is preferentially distributed on the endothelial side of the basement membrane where a peak of labelling is observed. From this peak, the labelling decreases towards the epithelial side. In contrast, in diabetic animals the labelling is more uniformly distributed through the entire thickened basement membrane. Labellings for M2* and M3 monomers in control and in diabetic animals are found to be distributed over the entire thickness of the lamina densa, few gold particles being present over the laminae rarae.
The specificity of the results as well as the absence of maj or cross reactivity between the antibodies were demonstrated by immunoblot analysis [28, 40] and by our labelling experiments. Indeed, incubation of tissue sections with a normal rabbit serum prior to the protein A-gold step resulted in very low labelling, only scattered gold particles were seen on the tissue. This demonstrates absence of nonspecific interactions of immunoglobulins to the tissue sections. Incubation with the protein A-gold alone also resulted in an absence of labelling (results not shown). 
Discussion
The streptozotocin-injected animals displayed metabolic changes related to diabetes, namely high blood glucose, low insulin levels, proteinuria and deficiency in weight gain as reported previously [41, 42] . They also displayed the typical kidney alterations described in experimental diabetes [43] with significant thickening of the glomerular basement membrane and accumulation of mesangial matrix [41, 42] . A relative thickening of the glomerular basement membrane was also observed with aging in control animals which confirms previous results [42, 43] . The absence of direct effect of streptozotocin on the development of these alterations was demonstrated previously [44, 45] .
Studies performed on the NC1 domain of type IV collagen from bovine glomerular basement membrane led to the conclusion that two new collagenous chains designated c~3(IV) and cx4(IV) do exist beside the ~I(IV) and cz2(IV) chains [28, 29] . Immunocytochemical studies have previously demonstrated that these chains are not codistributed in normal renal basement membranes [30] [31] [32] nor in human diabetic glomerular basement membrane [34] . On the other hand, in diabetic conditions the distribution of type IV collagen in glomerular basement membrane was found to be altered [20] . These data prompted us to further investigate at the ultrastructural level, possible changes in the distribution of M1, M2* and M3 monomers in renal basement membrane of diabetic rats. To do so, we used specific polyclonal antibodies and applied the protein A-gold immunocytochemical technique to reveal with high resolution these monomers in renal basement membranes of control and long-term diabetic rats. The heterogeneous distribution of M1, M2* and M3 monomers described previously in renal basement membranes of 3-months-old normoglycaemic rats [32] was confirmed in the present study on renal tissue of 12-months-old control animals. In the diabetic condition however, we found changes in the distribution of the monomers and in the intensity of their immunolabellings. These modifications varied according to the monomer analysed as well as to the basement membrane considered. Indeed, a 1.5 to 2-fold increase in the labelling intensities of M1 and M2* monomers was observed for proximal tubule and Bowman's capsule basement membranes of diabetic animals, while the intensity of M3 labelling remained unchanged. The labelling for each monomer appeared equally distributed over the entire area of these basement membranes in control and diabetic animals. On the other hand, evolution of glomerular basement membrane and mesangial matrix immunolabellings in glomeruli from diabetic rats was quite distinct. The labelling intensities of M1 and M2* monomers were increased within the glomerular basement membrane but remained unchanged in the mesangial matrix. Furthermore, the ultrastructural distribution of M1 monomers was altered. It was present through the entire thickness of the basement membrane in diabetic animals whereas it predominated on the endothelial side in controls. For the M2* monomer, only an increase in its labelling intensity was observed, the distribution remaining the same. Finally, for the M3 monomer neither its labelling nor its distribution were modified during diabetes.
Our results, showing an overall increase in the labelling intensities of M1 and M2 monomers in glomerular basement membrane, could be related to an increase in their content which correlates with the biochemical demonstration of an accumulation of type IV collagen in basement membranes during diabetes [16, 17, 46] . However, new information is provided by our quantitative study demonstrating that the czl(IV) and c~2(IV) chains, recognized by the anti-M1 antibodies, and the a3(IV) chain, recognized by the anti M2* antibody, participate in the accumulation of collagenous material in diabetic renal basement membranes. Surprisingly, the o~4(IV) chain appears not to be involved in this process. Concerning basement membranes of the glomeruli, an unexpected finding is the striking difference observed between the mesangial matrix and the peripheral basement membrane. Expansion of the matrix within the mesangial area is a distinctive and constant lesion in diabetic glomerulosclerosis. This, together with the accumulation of type IV collagen extracted from diabetic glomeruli, suggests that this accumulation would take place in mesangial matrix. Our study has, however, clearly demonstrated that the increased concentration of od(IV) and ~2(IV) chains of type IV collagen does not occur in the mesangial matrix but rather in the peripheral glomerular basement membrane. The discrepency between the stability of the various chains of the mesangial type IV collagen and their imbalance in the peripheral basement membrane could not have been detected by biochemical M. Desjardins et ai.: Type IV collagen distribution in diabetes methods where the mesangial matrix and the peripheral basement membranes are extracted and analysed as a whole. These results show that the glomerular basement membrane and the extracellular matrix of the mesangial area differ not only in their collagen composition but also in their response to the metabolic disturbances induced by diabetes.
In renal basement membranes from diabetic animals, the absence of detectable modifications in M3 monomer in contrast to the marked increase in M2* monomer is interesting to consider. These monomers have been previously shown to be codistributed within renal basement membranes in normal conditions [32] . In addition, the absence of M2* monomer in patients affected with A1-port's syndrome has also been correlated with an absence of the M3 monomer (unpublished personal data). This codistribution of M2* and M3 monomers could suggest that the cz3(IV) and ~x4(IV) chains belong to the same molecule. However, our data in the diabetic rats where only the M2* monomer is increased, suggest that cz3(IV) and o~4(IV) chains may in fact belong to different molecules. Another hypothesis could be that the molecular arrangement of these collagen chains is modified during diabetes. To what extent modification of the basement membrane morphological and structural integrity alter their functional properties is under investigation. The study should not be limited to type IV collagen since changes in the non-collagenous components of the basement membrane suclh as laminin and heparan sulfate proteoglycan have also been reported during diabetes [19, 47, 48] . Non-enzymatic glycosylation also affects basement membrane components [4%52] and their binding properties [53] . All these results suggest that an important reorganisation of the structure of basement membranes must take place during diabetes as a consequence of the unbalanced content of their various components and their biochemical modifications.
Our study thus demonstrates alterations in the type IV collagen composition of basement membranes during diabetes. These alterations are characterized by an increase in M1 and M2* monomers, corresponding to the od(IV), o~2(IV) and cz3(IV) chains of type IV collagen, in all renal basement membrane studied except in the mesangial matrix. The M3 monomer, corresponding to the cz4(IV) chain was, however, not altered. In addition, modifications in the spatial distribution of M1 monomers were observed in the glomerular basement membrane. These results demonstrate that the colIagenous nature of some basement membranes are significantly modified during diabetes. The importance of these modifications suggests that a rearrangement of the structural organization of basement membranes and particularly of the glomerular basement membrane occurs, possibly leading to alterations in their functional properties.
